The clinical relevance of BAALC and ERG expression levels in pediatric AML.
M C H
MC
Hermkens
M M
MM
van den Heuvel-Eibrink
S T C J M
ST
Arentsen-Peters
A
A
Baruchel
J
J
Stary
D
D
Reinhardt
M
M
Zimmerman
V
V
de Haas
R
R
Pieters
C M
CM
Zwaan
D014408:Biomarkers, Tumor / Q000235:genetics*; D002648:Child; D015331:Cohort Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000401:mortality; D009363:Neoplasm Proteins / Q000235:genetics*; D009364:Neoplasm Recurrence, Local / Q000235:genetics* / Q000401:mortality; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015996:Survival Rate; D015534:Trans-Activators / Q000235:genetics*; D000071230:Transcriptional Regulator ERG
C442828:BAALC protein, human; D014408:Biomarkers, Tumor; C072312:ERG protein, human; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG